Transparency

Eisai has defined “compliance”—strict adherence to legal and ethical standards—as the foundation of its business activities.

Eisai Pharma AG has also signed the Pharmaceutical Cooperation Code. The Code of Conduct for the pharmaceutical industry in Switzerland governs collaboration with healthcare professionals and patient organizations.

Eisai GesmbH - Transparency

Reports Transparency
Payments HCP/HCOs

Reports Transparency
Payments Patient Organisation

Disclosure Self Certification

Research and development at Eisai

Find out more about research and development at Eisai on the Eisai co. UK.

Eisai conducts research and development in the key areas of neurology and oncology. Active ingredient research, drug development and clinical research are carried out in the company’s own research facilities worldwide.

Eisai Pharma AG - Company - Eisai is one of the world's leading pharmaceutical companies headquartered in Japan

Company

Eisai – a human health care (hhc) company

Eisai is one of the world’s leading research and development-oriented pharmaceutical companies. We research, develop and distribute products in areas where there is still a great therapeutic need.

Eisai Pharma AG is the Swiss subsidiary of the Eisai Group, a research-based pharmaceutical company headquartered in Tokyo, Japan.

Eisai in Switzerland

Eisai Pharma AG

Eisai Pharma AG is the Swiss subsidiary of the Eisai Group, a research-based pharmaceutical company headquartered in Tokyo, Japan. Eisai has been marketing and distributing its medicines for the Swiss market from Zurich since 2005. Our employees work in the areas of sales & marketing, medical affairs, regulatory affairs, finance and pharmaceutical services.

Eisai Pharma AG

News

Eisai Global

Press releases from the Group can be found on the website of Eisai Co., Ltd.